Top 10 Companies in the (S)-1-[4-(Trifluoromethyl)Phenyl]Ethylamine Market (2026): Market Leaders Powering Global Chemical Innovation

MARKET INSIGHTS

Global (S)-1-[4-(Trifluoromethyl)Phenyl]Ethylamine market size was valued at USD 28.4 million in 2025. The market is projected to grow from USD 30.6 million in 2026 to USD 58.2 million by 2034, exhibiting a CAGR of 7.4% during the forecast period.

(S)-1-[4-(Trifluoromethyl)Phenyl]Ethylamine is a chiral amine compound characterized by the presence of a trifluoromethyl group on the phenyl ring and a single stereocenter in the (S)-configuration. It serves as a critical building block and chiral resolving agent in asymmetric synthesis, pharmaceutical intermediate manufacturing, and the development of agrochemical compounds. Its high enantiomeric purity and chemical stability make it particularly valuable in the synthesis of biologically active molecules.

The market is witnessing steady expansion driven by growing demand for enantiopure intermediates in drug discovery and the rising adoption of chiral chemistry across the pharmaceutical and specialty chemicals sectors. Furthermore, the increasing focus on fluorinated compounds in medicinal chemistry – owing to their enhanced metabolic stability and bioavailability – continues to elevate the relevance of this compound. Key suppliers operating in the global market include Alfa Aesar, TCI Chemicals, and Sigma‑Aldrich (MilliporeSigma), among others offering this compound across research and commercial‑scale applications.

(S)-1-[4-(Trifluoromethyl)Phenyl]Ethylamine Market – View in Detailed Research Report

---

🔟 1. Thermo Fisher Scientific (Alfa Aesar)

Headquarters: Waltham, Massachusetts, USA
Key Offering: High‑purity (≥99% ee) (S)-1-[4-(Trifluoromethyl)Phenyl]Ethylamine, supporting API synthesis and research.

Thermo Fisher Scientific’s Alfa Aesar brand provides a broad portfolio of fine chemicals, including enantiopure chiral amines. Their (S)-1-[4-(Trifluoromethyl)Phenyl]Ethylamine is produced via proprietary asymmetric hydrogenation, ensuring consistent enantiomeric excess above 99%. The company offers extensive analytical support, including certificates of analysis, NMR, and HPLC data.

Sustainability & Growth Initiatives:

• Investments in green hydrogenation catalysts to reduce CO₂ footprint.
• Digital lab notebooks for real‑time synthesis monitoring.
• Strategic partnerships with CDMOs to scale up supply for pharma.

Thermo Fisher’s commitment to quality and regulatory compliance positions it as a trusted partner for pharmaceutical developers seeking reliable chiral building blocks.

🔟 2. TCI Chemicals

Headquarters: Tokyo, Japan / Europe
Key Offering: Research‑grade (97–98% ee) and technical‑grade (≥95% ee) (S)-1-[4-(Trifluoromethyl)Phenyl]Ethylamine.

TCI Chemicals supplies a range of chiral amines for academic and industrial research. Their (S)-1-[4-(Trifluoromethyl)Phenyl]Ethylamine is produced using chiral resolution of racemate, offering cost‑effective solutions for early‑stage synthesis.

Sustainability & Growth Initiatives:

• Implementation of solvent‑free resolution protocols.
• Expansion of EU distribution network to support emerging markets.
• Collaborations with universities for catalyst development.

TCI’s focus on sustainability and regional accessibility makes it a preferred supplier for research institutions worldwide.

🔟 3. Alfa Chemistry

Headquarters: Boston, Massachusetts, USA
Key Offering: High‑purity (≥99% ee) (S)-1-[4-(Trifluoromethyl)Phenyl]Ethylamine for API synthesis.

Alfa Chemistry specializes in chiral intermediates, employing state‑of‑the‑art asymmetric hydrogenation and biocatalytic routes. They provide detailed process data and regulatory documentation to support cGMP manufacturing.

Sustainability & Growth Initiatives:

• Use of renewable feedstocks for precursor synthesis.
• Carbon‑neutral production facilities.
• Investment in AI‑driven reaction optimization.

Alfa Chemistry’s emphasis on green chemistry and regulatory alignment drives its leadership in the chiral building block market.

🔟 4. Asymchem Laboratories

Headquarters: Shanghai, China
Key Offering: Enantiopure (S)-1-[4-(Trifluoromethyl)Phenyl]Ethylamine for CDMO scale synthesis.

Asymchem offers scalable production using proprietary asymmetric hydrogenation catalysts. Their product is tailored for contract development and manufacturing organizations, providing batch‑to‑batch consistency and full regulatory support.

Sustainability & Growth Initiatives:

• Low‑energy consumption processes.
• Waste‑minimization through catalyst recycling.
• Partnerships with global CDMOs for market expansion.

Asymchem’s focus on process efficiency and sustainability makes it a go‑to supplier for large‑scale chiral synthesis.

🔟 5. Capot Chemical Co., Ltd.

Headquarters: Guangzhou, China
Key Offering: Cost‑effective (S)-1-[4-(Trifluoromethyl)Phenyl]Ethylamine for research and pilot‑scale projects.

Capot Chemical utilizes chiral resolution techniques to deliver high‑purity material at competitive prices. They support a wide range of applications, from academic research to early‑stage drug development.

Sustainability & Growth Initiatives:

• Adoption of green solvents in resolution processes.
• Energy‑efficient production lines.
• Expansion into Southeast Asian markets.

Capot Chemical’s value proposition lies in affordable, high‑quality chiral intermediates.

🔟 6. Nanjing Chemlin Chemical Industry Co., Ltd.

Headquarters: Nanjing, China
Key Offering: Research‑grade (S)-1-[4-(Trifluoromethyl)Phenyl]Ethylamine with customizable purity.

Chemlin delivers enantiopure amines through chiral resolution and biocatalytic methods. They provide detailed analytical reports and support for regulatory submissions.

Sustainability & Growth Initiatives:

• Implementation of closed‑loop solvent recovery.
• Carbon‑offset projects.
• Strategic alliances with European CDMOs.

Chemlin’s focus on sustainable manufacturing enhances its appeal to environmentally conscious developers.

🔟 7. ABCR GmbH

Headquarters: Frankfurt, Germany
Key Offering: High‑purity (≥99% ee) (S)-1-[4-(Trifluoromethyl)Phenyl]Ethylamine for API and agrochemical synthesis.

ABCR employs advanced organocatalytic routes, providing rapid, scalable production with minimal waste. They maintain strict GMP compliance for pharmaceutical use.

Sustainability & Growth Initiatives:

• Use of biodegradable catalysts.
• Zero‑waste production processes.
• Investment in digital supply chain transparency.

ABCR’s commitment to zero‑waste and digitalization positions it as a forward‑looking supplier.

🔟 8. Fluorochem Ltd.

Headquarters: London, United Kingdom
Key Offering: Specialty (S)-1-[4-(Trifluoromethyl)Phenyl]Ethylamine for agrochemical and specialty chemical research.

Fluorochem focuses on fluorinated building blocks, offering high‑purity material with tailored solvent compatibility for agrochemical processes.

Sustainability & Growth Initiatives:

• Green solvent development.
• Collaborations with agri‑tech companies.
• Carbon‑neutral logistics.

Fluorochem’s niche expertise supports the growing demand for fluorinated agrochemicals.

🔟 9. Oakwood Chemical

Headquarters: San Diego, California, USA
Key Offering: Technical‑grade (≥95% ee) (S)-1-[4-(Trifluoromethyl)Phenyl]Ethylamine for pilot‑scale synthesis.

Oakwood offers flexible packaging and rapid delivery for research labs, with robust analytical support.

Sustainability & Growth Initiatives:

• Energy‑efficient manufacturing.
• Renewable electricity usage.
• Partnerships with CDMOs for scale‑up.

Oakwood’s agility and sustainability focus make it a reliable partner for early‑stage development.

🔟 10. Sigma‑Aldrich (MilliporeSigma)

Headquarters: St. Louis, Missouri, USA
Key Offering: Comprehensive catalog of (S)-1-[4-(Trifluoromethyl)Phenyl]Ethylamine in high, standard, and technical grades.

Sigma‑Aldrich provides high‑quality chiral amines with extensive documentation, including certificates of analysis, purity data, and safety sheets.

Sustainability & Growth Initiatives:

• Implementation of green chemistry protocols.
• Carbon‑neutral supply chain initiatives.
• Investment in AI‑driven synthesis optimization.

Sigma‑Aldrich’s global reach and commitment to sustainability solidify its leadership in the chiral building block market.

---

Download FREE Sample Report: Download FREE Sample Report

Get Full Report Here: Get Full Report

---

🌍 Outlook: The Future of (S)-1-[4-(Trifluoromethyl)Phenyl]Ethylamine Market

The (S)-1-[4-(Trifluoromethyl)Phenyl]Ethylamine market is poised for sustained growth driven by expanding pharmaceutical R&D, increasing adoption of chiral chemistry, and the rise of fluorinated drug candidates. Technological advancements in asymmetric synthesis and biocatalysis are reducing production costs, while digital transformation is accelerating supply chain visibility.

Key growth drivers include:

• Expanding CDMO and CRO demand for high‑purity chiral intermediates.
• Growing CNS drug discovery pipeline leveraging the trifluoromethyl scaffold.
• Regulatory emphasis on enantiopure compounds in drug development.
• Investment in green chemistry and sustainable manufacturing.

Market participants are expected to capitalize on these trends by expanding production capacity, adopting AI‑driven process optimization, and forging strategic partnerships with CDMOs and academic institutions.

📈 Future Trends Shaping the Market

• Artificial intelligence and machine learning in reaction design and lead optimization.
• Biocatalytic routes enabling mild, scalable, and eco‑friendly synthesis.
• Integration of digital platforms for real‑time analytics and supply chain transparency.
• Emerging regulatory frameworks promoting single‑enantiomer drugs and green chemistry.

These developments are likely to accelerate the adoption of (S)-1-[4-(Trifluoromethyl)Phenyl]Ethylamine across pharmaceutical, agrochemical, and specialty chemical sectors.